Related Experiment Video
Updated: Sep 3, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Special Considerations in the Care of Women With Advanced Heart Failure
Imo A Ebong1, Ersilia M DeFilippis2, Eman A Hamad3
1Division of Cardiovascular Medicine, University of California, Davis, Sacramento, CA, United States.
Insights
Women face higher risks and inequities in advanced heart failure (AHF) care. This review explores sex hormones, clinical aspects, and therapies for AHF in women, highlighting pregnancy, lactation, and menopause considerations.
Area of Science:
- Cardiology
- Reproductive Endocrinology
- Health Inequities
Background:
- Advanced heart failure (AHF) presents significant morbidity, mortality, and healthcare burdens.
- Current AHF therapy allocation shows persistent inequities, particularly affecting women.
- Women experience higher AHF-related mortality and are less referred for advanced therapies like heart transplantation or ventricular assist devices.
Purpose of the Study:
- To review the influence of sex hormones on AHF pathophysiology.
- To describe the clinical presentation, diagnosis, and treatment of AHF in women.
- To address specific considerations for women including pregnancy, lactation, contraception, and menopause.
Main Methods:
- Literature review focusing on sex-specific factors in AHF.
- Analysis of clinical presentation and diagnostic criteria for AHF in women.
- Examination of advanced therapy referral patterns and outcomes for women.
Main Results:
- Sex-specific risk factors significantly impact AHF progression in women.
- Hormonal influences on AHF pathophysiology require further investigation.
- Disparities exist in access to advanced AHF therapies for women.
Conclusions:
- Understanding sex hormones is crucial for managing AHF in women.
- Addressing inequities in AHF care is essential for improving outcomes.
- Further research is needed to optimize AHF management strategies for women across their lifespan.
Abstract:
Advanced heart failure (AHF) is associated with increased morbidity and mortality, and greater healthcare utilization. Recognition requires a thorough clinical assessment and appropriate risk stratification. There are persisting inequities in the allocation of AHF therapies. Women are less likely to be referred for evaluation of candidacy for heart transplantation or left ventricular assist device despite facing a higher risk of AHF-related mortality. Sex-specific risk factors influence progression to advanced disease and should be considered when evaluating women for advanced therapies. The purpose of this review is to discuss the role of sex hormones on the pathophysiology of AHF, describe the clinical presentation, diagnostic evaluation and definitive therapies of AHF in women with special attention to pregnancy, lactation, contraception and menopause. Future studies are needed to address areas of equipoise in the care of women with AHF.
More Related Videos
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Cardiomyopathy VI: Nursing Management
Heart Failure V: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis IV: Nursing Management

